Presidio Property Trust, Inc. Announces Earnings for the First Quarter Ended March 31, 2021
SAN DIEGO, CA / ACCESSWIRE / May 11, 2021 / Presidio Property Trust, Inc. (NASDAQ:SQFT) (the Company ), an internally-managed, diversified REIT, with holdings in office, industrial, retail, and model home properties, today reported financial results for its first quarter ended March 31, 2021. All first quarter financial measures referenced herein are unaudited. We are pleased to report our first quarter earnings, continuing the strong rent collections that we saw throughout 2020, said Jack Heilbron, the Company s President and Chief Executive Officer. The diversified nature of our portfolio, with especially strong office and model home collections, resulted in a company-wide collections rate of 96% of budget in the first quarter of 2021.
$46,020
Gross Margin was 74% during the first quarter of 2021, as compared to 83% in the first quarter of 2020. The compression in gross margin for the first quarter of 2021 was driven by revenue mix including the launch of TREAKISYM product sales to our partner in the first quarter of 2021, on which we earn no profit.
R&D expense was $14.3 million for the first quarter of 2021, compared to $9.4 million in the first quarter of 2020. The increase is largely attributable to $2.6 million in development costs for vasopressin, a $0.9 million increase in the cost for fulvestrant, and a $0.9 million increase in development costs for RYANODEX related projects. Excluding stock-based compensation and other non-cash and non-recurring items, R&D expense during the first quarter of 2021 was $13.1 million.
Share this article
Share this article
ATLANTA, May 10, 2021 /PRNewswire/ Preferred Apartment Communities, Inc. (NYSE: APTS) ( we, our, the Company, Preferred Apartment Communities or PAC ) today reported results for the quarter ended March 31, 2021. Unless otherwise indicated, all per share results are reported based on the basic weighted average shares of Common Stock and Class A Units ( Class A Units ) of the Preferred Apartment Communities Operating Partnership (our Operating Partnership ) outstanding. See Definitions of Non-GAAP Measures.
Preferred Apartment Communities We are very pleased to report another quarter of sound operational performance from our Sunbelt-focused portfolio of assets. We are seeing solid growth and positive trajectory in our top line revenues in our core multifamily business, which is supported by broad positive economic and migration trends. These operational successes have allowed us to continue to advance our strategic goals of simplify
Gladstone Commercial Corporation Reports Results for the First Quarter Ended March 31, 2021
ACCESSWIRE
11 May 2021, 06:31 GMT+10
Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment.
MCLEAN, VA / ACCESSWIRE / May 10, 2021 / Gladstone Commercial Corporation (NASDAQ:GOOD) ( Gladstone Commercial or the Company ) today reported financial results for the first quarter ended March 31, 2021. A description of funds from operations, or FFO, and Core FFO, both non-GAAP (generally accepted accounting principles in the United States) financial measures, are located at the end of this press release. All per share references are to fully-diluted weighted average shares of common stock and Non-controlling OP Units, unless otherwise noted. For further detail, please also refer to both the quarterly financial supplement and the Company s Quarterly Report on Form 10-Q, which can be retrieved from the investors section
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
Catalyst Pharmaceuticals, Inc.May 10, 2021 GMT
-Firdapse® Q1 2021 Net Revenues of $30.2 Million
-First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million
-Recently Received Orphan Drug Designation for Firdapse® in Japan
-$143.3 Million in Cash and Investments and no Funded Debt at end of Q1-2021
-Catalyst to Host Quarterly Conference Call at 8:30 AM ET Tomorrow
CORAL GABLES, Fla., May 10, 2021 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today reported financial results for the first quarter ended March 31, 2021 and provided a business